Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Palisade Bio Inc. buy Brookline Capital Management

Palisade Bio Inc.
Start price
€0.34
13.05.25 / 50%
Target price
€14.40
13.05.26
Performance (%)
-
End price
-
14.05.26
Summary
This prediction was cancelled by the user.
Performance without dividends (%)
Name 1w 1m 1y
Palisade Bio Inc. - - -
iShares Core DAX® -0.874% 5.325% 6.865%
iShares Nasdaq 100 -0.381% 1.979% 25.696%
iShares Nikkei 225® -1.676% 1.952% 41.443%
iShares S&P 500 -0.655% 2.069% 21.405%

Comments by Brookline_Capital_Ma for this prediction

In the thread Trading Palisade Bio Inc.
Prediction Buy
Perf. (%) -
Target price 14.405
Change
Ends at 13.05.26

Die von Brookline_Capital_Ma gewählte maximale Laufzeit wurde überschritten

Brookline Capital Management 
0
Report Share
14.05.26
In the thread Palisade Bio Inc. diskutieren
Prediction Buy
Perf. (%) -
Target price 14.405
Change
Ends at 13.05.26

Palisade Bio, Inc. (NASDAQ: PALI) had its "buy" rating re-affirmed by analysts at Brookline Capital Management. They now have a $16.00 price target on the stock.
Ratings data for PALI provided by MarketBeat

Brookline Capital Management 
0
Report Share
13.05.25

Stopped prediction by Brookline_Capital_Ma for Palisade Bio Inc.

buy
Palisade Bio Inc.

Start price
Target price
Perf. (%)
€0.34
20.11.24
€36.03
20.11.25
-
21.11.25

Brookline Capital Management 
20.11.24 50%